HealthTree Foundation for Multiple Myeloma

At first relapse in multiple myeloma, there are more effective options than ever before. What would you choose?

👉 Comment below: What factors would influence your decision?

1 month ago | [YT] | 1

HealthTree Foundation for Multiple Myeloma

🎗️ Multiple Myeloma Awareness Month Spotlight: Nashville Roundtable Coverage! 🎗️

March is Multiple Myeloma Awareness Month, and there’s no better time to come together, learn, and share hope. 💛

We’re excited to share the full coverage of HealthTree’s Multiple Myeloma Roundtable held in Nashville, Tennessee! This event brought together patients, caregivers, and experts to discuss the latest insights, treatments, and personal experiences in the fight against multiple myeloma.

Whether you’re newly diagnosed, a long-term survivor, or supporting a loved one, this video offers:
✅ Expert insights on treatment and care
✅ Stories from real patients and caregivers
✅ The power of community in navigating life with multiple myeloma

🌟 Join us in raising awareness, spreading knowledge, and connecting with others who understand the journey. Watch now and be part of the conversation!

youtube.com/playlist?list=PLJ...

2 months ago | [YT] | 2

HealthTree Foundation for Multiple Myeloma

Dara + Tec was recently FDA approved for first relapse in myeloma. Let's review the trial that led to this speedy FDA approval.

2 months ago | [YT] | 9

HealthTree Foundation for Multiple Myeloma

If you’re living with myeloma, one question often comes up:
“Is this something my family needs to worry about?”
In this HealthTree video — Is Myeloma Hereditary? A Guide to Screening for Family Members — we break down what research shows about family risk.

https://youtu.be/WGmlVYF5pyQ?si=k5eH7...

2 months ago | [YT] | 1

HealthTree Foundation for Multiple Myeloma

March is Myeloma Awareness Month 💚

But awareness isn’t just about wearing a ribbon — it’s about understanding the disease.

Did you know that multiple myeloma is not one single disease? There are different subtypes, based on the type of abnormal protein your myeloma cells produce and specific genetic features. These differences can influence how the disease behaves and how it’s monitored .

In this HealthTree video, we break down the different subtypes of multiple myeloma in clear, patient-friendly language — so you can better understand your diagnosis and have more informed conversations with your healthcare team.
If you or a loved one is living with myeloma, this is foundational knowledge. And if you’re part of this community, sharing education is one powerful way we raise awareness.

💚 Take a few minutes to watch.
💚 Share it with someone who needs it.
💚 Let’s make awareness meaningful.

2 months ago | [YT] | 3

HealthTree Foundation for Multiple Myeloma

Today is the first day of Myeloma Awareness Month 💚 — a time to learn, share, and empower.

This morning I rewatched a classic HealthTree University lesson where Dr. Morie Gertz explains multiple myeloma using a simple but powerful analogy: a garden.
If you’ve watched it before, it’s worth a rewatch. And if you haven’t seen it yet, I encourage you to take a few minutes to do so. Education is one of our strongest tools this awareness month. 💚

2 months ago | [YT] | 11

HealthTree Foundation for Multiple Myeloma

What’s the biggest challenge you think people face when it comes to understanding multiple myeloma?

2 months ago | [YT] | 4

HealthTree Foundation for Multiple Myeloma

For years, “cure” was never mentioned in myeloma.

Now, the International Myeloma Society has proposed a definition of what cure could mean.

Proposed Definition of Cure

-Patient could be NDMM or RRMM
-Patient is sustained CR by standard criteria
-MRD negative at the sensativity of 1 in 1,000,000 cells by either NGS or NGF
-MRD negativity sustained for 5 years WITHOUT any therapy (irrespective of length of previous sustained MRD negativity on therapy)
-There should be at least 4 MRD assessments in 5 years , last one being at 5 years, all negative and no positive in between, if oerformed
-Negative by functional imaging (PET/CT or DWI WB MRI) - at least at the beginning of 5 year period and at the end of 5 year period with no intervening positivity


💬 Based on that definition — is myeloma a curable malignancy?

2 months ago | [YT] | 10

HealthTree Foundation for Multiple Myeloma

The International Myeloma Society (IMS) — a global professional organization dedicated to advancing research, education, and clinical care in multiple myeloma — met this past Friday and Saturday with one extraordinary goal: to define what “cure” will mean in myeloma.

After thoughtful discussion and expert consensus, they agreed upon a formal definition.

Let that sink in.

For those of us in the myeloma community, this is monumental. When I was diagnosed in 2008, “cure” was a four-letter word that was never spoken. It wasn’t part of the conversation. It wasn’t part of the expectations.

Today, not only is the word being spoken — it is being defined.

This marks a powerful shift in mindset, research focus, and possibility for patients everywhere.

Thank you to the entire myeloma community — the researchers who pushed the science forward, the clinicians who translated discovery into care, the organizations that funded lifesaving trials, and most importantly, the patients who enrolled in clinical trials and never gave up.

Because of you, we are no longer just treating myeloma.

We are defining cure.

2 months ago | [YT] | 7

HealthTree Foundation for Multiple Myeloma

The US FDA accepts BMS's application for Iberdomide in Patients with Relapsed Refractory Myeloma- Check out HealthTree's Therapies on the Horizon video on Iber

2 months ago | [YT] | 2